Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 22972301000001119 | Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 43763801000001114 | Dronabinol 2.7mg/dose / Cannabidiol 2.5mg/dose oromucosal spray 102 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 4 (CD Benz) | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Is pack of | Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray | false | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has active ingredient | Cannabidiol | false | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has active ingredient | Tetrahydrocannabinol | false | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has active ingredient | Dronabinol | false | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has VMP | Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has specific active ingredient | Dronabinol | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has specific active ingredient | Cannabidiol | true | Inferred relationship | Existential restriction modifier | ||
| Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses | Is a | True | Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR